Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 18;56(6):972-979.
doi: 10.19723/j.issn.1671-167X.2024.06.005.

[Immunological characteristics of patients with anti-synthetase syndrome overlap with rheumatoid arthritis]

[Article in Chinese]
Affiliations

[Immunological characteristics of patients with anti-synthetase syndrome overlap with rheumatoid arthritis]

[Article in Chinese]
Liang Zhao et al. Beijing Da Xue Xue Bao Yi Xue Ban. .

Abstract

Objective: To investigate the clinical and immunological characteristics of anti-synthetase syndrome (ASS) patients overlap with rheumatoid arthritis (RA).

Methods: A retrospective analysis was conducted on ASS patients with arthritis who were treated at Peking University People' s Hospital. Data collected included demographic information, clinical manifestations, laboratory features, lymphocyte subsets in peripheral blood, and treatments. The patients with ASS were divided into two groups based on the presence or absence of RA for comparative analysis.

Results: A total of 104 ASS patients with arthritis were included, among whom 23.1% (24/104) were diagnosed with RA. The ASS with RA group had a significantly higher incidence of rapidly progressive interstitial lung disease (RP-ILD) (41.7% vs. 17.6%, P=0.032), number of tender joints [10 (7, 14) vs. 4 (0, 8), P < 0.001], number of swollen joints [4 (2, 8) vs. 2 (0, 4), P=0.012], and rate of bone erosion (47.8% vs. 2.5%, P < 0.001) compared with the non-RA group. Levels of platelets [(289.57±68.74)×103/μL vs. (247.94±77.04)×103/μL, P=0.022], erythrocyte sedimentation rate (ESR) [43 (19, 59) mm/h vs. 18 (10, 44) mm/h, P=0.019], and C-reactive protein (CRP) [19.20 (4.80, 55.36) mg/L vs. 5.68 (1.10, 14.96) mg/L, P=0.006] were found significantly higher in the ASS with RA group than those in non-RA group. Analysis of immune cells in peripheral blood mononuclear cell (PBMC) showed that significantly decreased proportions of CLA+ Treg cells [(11.12±4.10)% vs. (17.22±8.49)%, P=0.003], B cells [8.56% (4.80%, 11.90%) vs. 14.55% (8.75%, 20.29%), P=0.025], and natural killer (NK) cells [7.56% (4.65%, 13.20%) vs. 13.25% (7.46%, 19.25%), P=0.045] in the overlap group compared with non-RA group. Proportion of Naïve Th cells [(52.66±17.66)% vs. (40.76±14.96)%, P=0.033)] was significantly increased in overlap group compared with non-RA group. Overlap group had lower rate of complete clinical response than non-RA group (16.7% vs. 43.8%, P=0.031).

Conclusion: Among ASS patients with arthritis, those with RA have more severe lung and joint involvement and a lower treatment response rate, highlighting the need for early recognition and aggressive intervention.

目的: 探究抗合成酶综合征(anti-synthetase syndrome, ASS)重叠类风湿关节炎(rheumatoid arthritis, RA)患者的免疫学特点。

方法: 回顾性分析北京大学人民医院住院的104例ASS伴有关节炎患者的资料,包括人口学资料、临床表现(皮疹、肌肉损害等)、实验室检查结果、外周血淋巴细胞亚群和治疗用药,依据患者是否重叠RA进行分组并比较。

结果: 104例ASS伴有关节炎的患者中,明确诊断RA的患者占23.1%(24/104例),ASS重叠RA组患者的快速进展型间质性肺炎(rapid progressive interstitial lung disease, RP-ILD)发生率(41.7% vs. 17.6%,P=0.032)、压痛关节数[10 (7, 14)个vs. 4 (0, 8)个,P<0.001]、肿胀关节数[4 (2, 8)个vs. 2 (0, 4)个,P=0.012]及骨侵蚀发生率(47.8% vs. 2.5%,P<0.001)均显著高于非RA组。实验室检查方面,血小板水平[(289.57±68.74)×103/μL vs. (247.94±77.04)×103/μL, P=0.022]、红细胞沉降率[43 (19, 59) mm/h vs. 18 (10, 44) mm/h, P=0.019]和C反应蛋白[19.20 (4.80, 55.36) mg/L vs. 5.68 (1.10, 14.96) mg/L, P=0.006] 在ASS重叠RA组的患者中显著升高。免疫学指标检查显示,与ASS合并关节炎的患者组相比,ASS重叠RA组患者的外周血CLA+Treg细胞[(11.12±4.10)% vs. (17.22±8.49)%,P=0.003]、B细胞[8.56% (4.80%, 11.90%) vs. 14.55% (8.75%, 20.29%),P=0.025]、自然杀伤(natural killer,NK)细胞[7.56% (4.65%, 13.20%) vs. 13.25% (7.46%, 19.25%),P=0.045] 的比例显著降低,Naïve Th细胞[(52.66±17.66)% vs. (40.76±14.96)%,P=0.033]的比例显著升高。治疗反应方面,ASS重叠RA组患者的完全临床应答率较低(16.7% vs. 43.8%, P=0.031)。

结论: ASS重叠RA患者的肺部及关节受累更严重,治疗应答率低,对此类患者需早期识别并积极干预。

Keywords: Anti-synthetase syndrome; Complete clinical response; Lymphocyte subsets; Rheumatoid arthritis.

PubMed Disclaimer

Conflict of interest statement

利益冲突 所有作者均声明不存在利益冲突。

Figures

图 1
图 1
ASS重叠RA和非RA患者完全临床应答率比较 Proportion of complete clinical response in patients with ASS overlap with RA and non-RA

References

    1. Marguerie C, Bunn CC, Beynon HL, et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med. 1990;77(282):1019–1038. - PubMed
    1. Aggarwal R, Cassidy E, Fertig N, et al. Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Ann Rheum Dis. 2014;73(1):227–232. doi: 10.1136/annrheumdis-2012-201800. - DOI - PMC - PubMed
    1. Hervier B, Devilliers H, Stanciu R, et al. Hierarchical cluster and survival analyses of antisynthetase syndrome: Phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmun Rev. 2012;12(2):210–217. doi: 10.1016/j.autrev.2012.06.006. - DOI - PubMed
    1. Labrador-Horrillo M, Martinez MA, Selva-O'Callaghan A, et al. Anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with idiopathic inflammatory myopathy. Rheumatology (Oxford) 2009;48(6):676–679. doi: 10.1093/rheumatology/kep065. - DOI - PubMed
    1. Cavagna L, Nuno L, Scirè CA, et al. Clinical spectrum time course in anti Jo-1 positive antisynthetase syndrome: Results from an international retrospective multicenter study. Medicine (Baltimore) 2015;94(32):e1144. doi: 10.1097/MD.0000000000001144. - DOI - PMC - PubMed

Publication types

Supplementary concepts